Purple Biotech GAAP EPADS of -$0.57

2 hours ago 1

Purple Biotech press release (NASDAQ:PPBT): Q2 GAAP EPADS of -$0.57.
As of June 30, 2025, Purple Biotech had cash and cash equivalents and short-term deposits of $5.6 million. The Company cash runway is expected into the third quarter of 2026.

Recommended For You